NENCY ANTOINE: Open Payments
NPI 1457041097 · BLOOMFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 15 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $561 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $93 |
| Novo Nordisk Inc | 2 | $62 |
| Actelion Pharmaceuticals US, Inc. | 1 | $36 |
| Corcept Therapeutics | 1 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Seqirus USA Inc | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: KRYSTEXXA, OTEZLA, OPSUMIT, Ozempic, Korlym, Wegovy, XIFAXAN, ZORYVE.
Industry payments across CT — which companies pay providers there.
